Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation·1999
Same author

The costs of dialysis in the USA.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1997
Same author

Long-term survival of vascular accesses in a large chronic hemodialysis population.

Nephron·1995
Same author

Health care reform: truth in spending, dollars and sense.

Rhode Island medicine·1994
Same author

Renal osteodystrophy and dialysis artifacts as indicators of identification.

Forensic science international·1994
Same author

Drug-induced renal disease.

Hospital practice (Office ed.)·1993
Same journal

Correction to I.M. Matters News: Sleep medicine for seniors.

Annals of internal medicine·2026
Same journal

Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

Annals of internal medicine·2026
Same journal

Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

Annals of internal medicine·2026
Same journal

Grappling with GLP-1 prescribing.

Annals of internal medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 27, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

Prolonged hemolysis from overheated dialysate.

S L Berkes, S I Kahn, J A Chazan

    Annals of Internal Medicine
    |September 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Overheated dialysate during dialysis can cause delayed red blood cell damage (hemolysis). The severity and duration of hemolysis depend on temperature and exposure time, highlighting the need for prevention strategies.

    More Related Videos

    An Open-Source Normothermic Perfusion System Designed for Research Scientists
    11:23

    An Open-Source Normothermic Perfusion System Designed for Research Scientists

    Published on: July 18, 2025

    Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
    06:23

    Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells

    Published on: November 21, 2025

    Related Experiment Videos

    Last Updated: Jun 27, 2026

    Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
    07:11

    Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

    Published on: July 19, 2018

    An Open-Source Normothermic Perfusion System Designed for Research Scientists
    11:23

    An Open-Source Normothermic Perfusion System Designed for Research Scientists

    Published on: July 18, 2025

    Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
    06:23

    Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells

    Published on: November 21, 2025

    Area of Science:

    • Nephrology
    • Hematology
    • Biomedical Engineering

    Background:

    • Chronic renal failure patients require dialysis for waste removal.
    • Dialysis involves extracorporeal blood circulation.
    • Maintaining dialysate temperature is critical for patient safety.

    Observation:

    • A patient with chronic renal failure experienced delayed hemolysis after 20 minutes of exposure to 50°C dialysate.
    • This contrasts with a previous case of sudden hemolysis and cardiac arrest.

    Findings:

    • Thermal injury to erythrocytes (red blood cells) causes hemolysis.
    • Hemolysis severity and duration correlate with dialysate temperature and exposure time.
    • Extracorporeal blood exposure to high temperatures is the primary cause.

    Implications:

    • Strict temperature control during dialysis is essential.
    • Preventive measures against dialysate overheating are crucial.
    • Understanding thermal injury mechanisms aids in managing dialysis complications.